Publications
Detailed Information
Analysis of Hemodialysis-Associated Hypoglycemia in Patients with Type 2 Diabetes Using a Continuous Glucose Monitoring System
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Hye Seung | - |
dc.contributor.author | Kim, Hong Il | - |
dc.contributor.author | Kim, Min Joo | - |
dc.contributor.author | Yoon, Ji Won | - |
dc.contributor.author | Cho, Young Min | - |
dc.contributor.author | Joo, Kwon Wook | - |
dc.contributor.author | Kim, Seong Yeon | - |
dc.contributor.author | Park, Kyong Soo | - |
dc.contributor.author | Lee, Jung Geon | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Ahn, Hwa Young | - |
dc.date.accessioned | 2012-06-27T05:57:19Z | - |
dc.date.available | 2012-06-27T05:57:19Z | - |
dc.date.issued | 2010-10 | - |
dc.identifier.citation | DIABETES TECHNOLOGY & THERAPEUTICS; Vol.12 10; 801-807 | ko_KR |
dc.identifier.issn | 1520-9156 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77590 | - |
dc.description.abstract | Background: Adequate glycemic control is important for patients with end-stage renal disease on maintenance hemodialysis (HD). Continuous glucose monitoring (CGM) systems are reported as a useful method for glucose monitoring in patients under maintenance HD. The object of this study was to describe glucose profiles and hypoglycemia associated with HD in diabetes patients using a CGM system. Methods: We recruited nine medically stable patients with type 2 diabetes under maintenance HD. CGMS (R) System Gold (R) (Medtronic MiniMed, Northridge, CA) was applied to the subjects for 144 h. During the period, HD using glucose-containing dialysate was performed every other day. Various glucose profiles were calculated from the CGM readings and compared between the day on and the day off dialysis. Results: Mean +/- SD for age, duration of diabetes, and hemoglobin A1c were 67 +/- 9 years, 24 +/- 9 years, and 8.6 +/- 1.2%, respectively. Hemoglobin A1c was correlated with mean glucose (rho = 0.780, P < 0.05) and with area under the curve for glucose above 180 mg/ dL (rho = 0.797, P < 0.05). Although there was no difference for mean amplitude of glycemic excursion between the day on and off HD, hypoglycemia occurred predominantly with day on HD. In the subjects who maintained antidiabetes agents with day on HD, glucose levels decreased with initiation of HD, causing significantly lower glucose levels compared to those during the equivalent time of the following day without HD. Conclusions: According to the CGM system, glucose variability was not affected by HD. However, in spite of glucose-containing dialysate, HD seemed to increase the risk of hypoglycemia. | ko_KR |
dc.description.sponsorship | This study was supported by a grant from the Korea Science
and Engineering Foundation (KOSEF) (0521-20080010) by the Ministry of Education, Science and Technology (MEST), by a grant from the Innovative Research Institute for Cell Therapy (A062260) by the Ministry of Health and Welfare, Republic of Korea, and by WCU project (R31-2008-000- 10103-0) of the MEST and the KOSEF. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | MARY ANN LIEBERT INC | ko_KR |
dc.title | Analysis of Hemodialysis-Associated Hypoglycemia in Patients with Type 2 Diabetes Using a Continuous Glucose Monitoring System | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정혜승 | - |
dc.contributor.AlternativeAuthor | 김홍일 | - |
dc.contributor.AlternativeAuthor | 김민주 | - |
dc.contributor.AlternativeAuthor | 윤지원 | - |
dc.contributor.AlternativeAuthor | 안화영 | - |
dc.contributor.AlternativeAuthor | 조영민 | - |
dc.contributor.AlternativeAuthor | 오국환 | - |
dc.contributor.AlternativeAuthor | 조권욱 | - |
dc.contributor.AlternativeAuthor | 이정건 | - |
dc.contributor.AlternativeAuthor | 김성연 | - |
dc.contributor.AlternativeAuthor | 박경수 | - |
dc.identifier.doi | 10.1089/dia.2010.0067 | - |
dc.citation.journaltitle | DIABETES TECHNOLOGY & THERAPEUTICS | - |
dc.description.citedreference | *INT DIAB FED, 2010, DIAB ATL | - |
dc.description.citedreference | *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS4 | - |
dc.description.citedreference | Drechsler C, 2009, CIRCULATION, V120, P2421, DOI 10.1161/CIRCULATIONAHA.109.857268 | - |
dc.description.citedreference | Riveline JP, 2009, NEPHROL DIAL TRANSPL, V24, P2866, DOI 10.1093/ndt/gfp181 | - |
dc.description.citedreference | Kazempour-Ardebili S, 2009, DIABETES CARE, V32, P1137, DOI 10.2337/dc08-1688 | - |
dc.description.citedreference | Kohnert KD, 2009, DIABETES CARE, V32, P1058, DOI 10.2337/dc08-1956 | - |
dc.description.citedreference | SHIM Y, 2009, KOREAN J NUTR, V42, P577 | - |
dc.description.citedreference | Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464 | - |
dc.description.citedreference | Wentholt IME, 2008, DIABETOLOGIA, V51, P183, DOI 10.1007/s00125-007-0842-6 | - |
dc.description.citedreference | *US REN DAT SYST, 2008, USRSD 2008 ANN DAT R | - |
dc.description.citedreference | Kohnert KD, 2007, DIABETES RES CLIN PR, V77, P420, DOI 10.1016/j.diabres.2007.01.021 | - |
dc.description.citedreference | Burmeister JE, 2007, NEPHROL DIAL TRANSPL, V22, P1184, DOI 10.1093/ndt/gfl710 | - |
dc.description.citedreference | Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789 | - |
dc.description.citedreference | Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681 | - |
dc.description.citedreference | Sangill M, 2006, AM J KIDNEY DIS, V47, P636, DOI 10.1053/j.ajkd.2006.01.007 | - |
dc.description.citedreference | Rigalleau V, 2005, CURR OPIN CLIN NUTR, V8, P463 | - |
dc.description.citedreference | Childs BP, 2005, DIABETES CARE, V28, P1245 | - |
dc.description.citedreference | TANSEY MJ, 2005, DIABETES TECHNOL THE, V7, P109 | - |
dc.description.citedreference | Loipl J, 2005, RENAL FAILURE, V27, P305, DOI 10.1081/JDI-200056608 | - |
dc.description.citedreference | Cryer PE, 2003, DIABETES CARE, V26, P1902 | - |
dc.description.citedreference | Djakoure-Platonoff C, 2003, DIABETES METAB, V29, P159 | - |
dc.description.citedreference | Guerci B, 2003, DIABETES CARE, V26, P582 | - |
dc.description.citedreference | *DIRECNET STUD GRO, 2003, DIABETES TECHNOL THE, V5, P781 | - |
dc.description.citedreference | Boland E, 2001, DIABETES CARE, V24, P1858 | - |
dc.description.citedreference | Morioka T, 2001, DIABETES CARE, V24, P909 | - |
dc.description.citedreference | Kovatchev BP, 2000, J CLIN ENDOCR METAB, V85, P4287 | - |
dc.description.citedreference | Jackson MA, 2000, CLIN NEPHROL, V54, P30 | - |
dc.description.citedreference | Haviv YS, 2000, RENAL FAILURE, V22, P219 | - |
dc.description.citedreference | Mastrototaro J, 1999, J PEDIATR ENDOCR MET, V12, P751 | - |
dc.description.citedreference | Nakao T, 1998, INTERNAL MED, V37, P826 | - |
dc.description.citedreference | 1998, LANCET, V352, P837 | - |
dc.description.citedreference | Davis SN, 1997, DIABETES, V46, P1328 | - |
dc.description.citedreference | Morgan L, 1996, DIABETIC MED, V13, P514 | - |
dc.description.citedreference | 1993, N ENGL J MED, V329, P977 | - |
dc.description.citedreference | MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67 | - |
dc.description.citedreference | DEFEO P, 1988, J CLIN INVEST, V82, P436 | - |
dc.description.citedreference | SCHWARTZ NS, 1987, J CLIN INVEST, V79, P777 | - |
dc.description.citedreference | SERVICE FJ, 1970, DIABETES, V19, P644 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.